Lenvatinib-d 4

Overview

Lenvatinib-d 4 is the deuterium labeled Lenvatinib. Lenvatinib (E7080) is an oral, multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, PDGFR , KIT, and RET , shows potent antitumor activities.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer | Products > Signaling Pathways > VEGFR | Products > Signaling Pathways > FGFR | Products > Signaling Pathways > PDGFR | Products > Signaling Pathways > c-Kit | Products > Signaling Pathways > RET

Product Information

• Catalog No.: HY-10981S
• CAS No.: 2264050-65-7
• Molecular Formula: C21H15D4ClN4O4
• Molecular Weight: 430.88
• Purity: 99.59%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source